When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 19 Sep 2025
Last updated: 14 Oct 2025

Summary

Definition

History and exam

Key diagnostic factors

  • cough
  • influenza-like illness
  • conjunctivitis
  • dyspnea
  • fever
  • rales, rhonchi
  • wheeze
  • decreased breath sounds
  • tachypnea

Other diagnostic factors

  • abdominal pain, vomiting, diarrhea
  • altered mental status
  • seizures

Risk factors

  • close contact with infected birds or poultry
  • close contact with infected animals or mammals
  • recent travel to a country with H5N1 virus outbreaks
  • environmental exposure to H5N1 virus
  • close contact with infected humans
  • laboratory work with H5N1 virus

Diagnostic tests

1st tests to order

  • CBC with differential
  • LFTs
  • chest x-ray
  • pulse oximetry
  • sputum Gram stain
  • sputum and blood bacterial culture
  • real-time reverse transcription polymerase chain reaction (rtRT-PCR)

Treatment algorithm

Contributors

Authors

Timothy M. Uyeki, MD, MPH, MPP

Chief Medical Officer

Influenza Division

National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

Atlanta

GA

Disclosures

TMU declares that he is an unpaid member and clinical Chair of the World Health Organization Guidelines Developmental Group: Clinical Management of Influenza Guidelines 2023-2024.

Acknowledgements

Dr Timothy M. Uyeki would like to gratefully acknowledge Dr Justin R. Ortiz, a previous contributor to this topic.

Disclosures

JRO declares that he has no competing interests.

Peer reviewers

Richard Martinello, MD

Professor

Departments of Internal Medicine and Pediatrics

Yale School of Medicine

New Haven

CT

Disclosures

RM declares that he has no competing interests.

An De Sutter, MD, PhD

Associate Professor

Department of General Practice and Primary Health Care

Ghent University

Belgium

Disclosures

ADS declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Centers for Disease Control and Prevention. Highly pathogenic avian influenza A(H5N1) virus: interim recommendations for prevention, monitoring, and public health investigations. Dec 2024 [internet publication].Full text

World Health Organization. Clinical practice guidelines for influenza. Sep 2024 [internet publication].Full text

Centers for Disease Control and Prevention. Avian influenza (bird flu): interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Jul 2025 [internet publication].Full text

Centers for Disease Control and Prevention. Avian influenza (bird flu): interim guidance for follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease or with potential to cause severe human disease, and use of antiviral medications for post-exposure prophylaxis. Jul 2025 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer